Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.

Woznowski M, Quack I, Stegbauer J, Büchner N, Rump LC, Schieren G.

Clin Nephrol. 2008 Nov;70(5):431-8. Erratum in: Clin Nephrol. 2008 Dec;70(6):564.

PMID:
19000546
2.

FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.

Quarles LD.

Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9. Review.

3.

[Hypophosphatemic osteomalacia].

Bullmann C, Benker G, Rosien U, Delling G, Siggelkow H, Schulte HM.

Med Klin (Munich). 2008 Sep 15;103(9):671-5. doi: 10.1007/s00063-008-1106-z. German.

PMID:
18813890
4.

Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.

Mori Y, Ogasawara T, Motoi T, Shimizu Y, Chikazu D, Tamura K, Fukumoto S, Takato T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar;109(3):e57-63. doi: 10.1016/j.tripleo.2009.10.052.

PMID:
20219587
5.

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H.

N Engl J Med. 2003 Apr 24;348(17):1656-63.

6.

A paranasal tumor associated with tumor-induced osteomalacia.

Inokuchi G, Tanimoto H, Ishida H, Sugimoto T, Yamauchi M, Miyauchi A, Nibu K.

Laryngoscope. 2006 Oct;116(10):1930-3.

PMID:
17003734
8.

Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.

Fukumoto S, Takeuchi Y, Nagano A, Fujita T.

Bone. 1999 Sep;25(3):375-7.

PMID:
10495143
9.

Acquired hypophosphatemic osteomalacia associated with multiple myeloma.

Narvaez J, Domingo-Domenech E, Narvaez JA, Nolla JM, Valverde J.

Joint Bone Spine. 2005 Oct;72(5):424-6.

PMID:
16112595
10.

Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report.

Pedrazzoli M, Colletti G, Ferrari M, Rossetti G, Moneghini L, Autelitano L.

Int J Oral Maxillofac Surg. 2010 Oct;39(10):1027-32. doi: 10.1016/j.ijom.2010.04.039.

PMID:
20483563
11.

What have we learnt about the regulation of phosphate metabolism?

Blumsohn A.

Curr Opin Nephrol Hypertens. 2004 Jul;13(4):397-401. Review.

PMID:
15199289
12.

Tumor-induced osteomalacia.

Hewison M.

Curr Opin Rheumatol. 1994 May;6(3):340-4. Review.

PMID:
8060772
14.

Tumor-induced osteomalacia.

Jan de Beur SM.

JAMA. 2005 Sep 14;294(10):1260-7.

PMID:
16160135
15.

Tumour-induced osteomalacia: a literature review and a case report.

Dadoniene J, Miglinas M, Miltiniene D, Vajauskas D, Seinin D, Butenas P, Kacergius T.

World J Surg Oncol. 2016 Jan 8;14(1):4. doi: 10.1186/s12957-015-0763-7. Review.

16.

Tumor-induced osteomalacia: a case of diagnostic dilemma.

Robertson A, Mansberg R, Mansberg V, Van der Wall H, Hooper M.

Clin Nucl Med. 2007 Aug;32(8):631-4.

PMID:
17667438
17.

[Phosphatonins: novel insights and clinical perspectives].

Mossetti G, Rendina D, De Filippo G, Zampa G, Strazzullo P.

G Ital Nefrol. 2009 Mar-Apr;26(2):171-80. Review. Italian.

PMID:
19382073
18.

Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.

Ungari C, Rocchi G, Rinna C, Agrillo A, Lattanzi A, Pagnoni M.

J Craniofac Surg. 2004 May;15(3):523-7.

PMID:
15111823
19.

Phosphate diabetes, tubular phosphate reabsorption and phosphatonins.

Laroche M, Boyer JF.

Joint Bone Spine. 2005 Oct;72(5):376-81. Review.

PMID:
16214071
20.

The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

Ledford CK, Zelenski NA, Cardona DM, Brigman BE, Eward WC.

Clin Orthop Relat Res. 2013 Nov;471(11):3618-25. doi: 10.1007/s11999-013-3178-1.

Items per page

Supplemental Content

Support Center